SCR-LIP-000657 · Claim · machine-readable JSON →

Benefits of liposuction for lipedema may be more sustained in earlier than in advanced disease stages.

General proposition consolidated from 2 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
3 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20172022Liposuction in the Treatment of Lipedema: A Longitudinal Study — Dadras et al. (2017) · consistentDisease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis — Ghods et al. (2022) · consistentComparative Analysis of Liposuction and Conservative Treatment in Lipedema Patients: A Modified Body-Q Questionnaire Study — Aitzetmüller-Klietz et al. (2022) · consistent

Evidence (3)

Context (PECO)

Populationlipedema patients, stage II–III (n=25)
Conditionlipedema
Exposuretumescent liposuction (mean 3 procedures)
Comparatorpre-operative baseline
Outcomepain VAS, QoL VAS, CDT scores at ~37 months
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log